Surgery linked to more urinary and sexual side effects, while radiation associated with other urinary complications and higher all-cause mortality ...
The WCLC 2026 conference saw updates on new antibody-drug conjugates and treatment protocols for small cell and non-small ...
Rahul Banerjee, MD, of Fred Hutchinson Cancer Center shares highlights from the International Myeloma Society (IMS) 2026 ...
Habitual coffee drinking may have protective effects against various types of cancer, according to a growing body of research ...
Hematologist and oncologist Amit Garg, MD, discusses the importance of using social media platforms to combat cancer ...
To analyze data on outcomes and health care utilization, researchers examined a large sample of American Indian/Alaska Native patients with cancer enrolled in traditional Medicare.
Phase 3 HER2CLIMB-05 trial demonstrates a 35.9% reduction in risk of disease progression or death with maintenance tucatinib combination.
Significant variation seen by race, with increased likelihood of MRI in non-Hispanic Whites versus non-Hispanic Blacks ...
A new report from the American Cancer Society provides cancer incidence, stage, survival, and mortality data for Hispanic/Latino people living in the US, as well as projected numbers of new cancer ...
For this study, researchers developed a deep-learning based system to quantify 3-dimensional cervical neck soft tissue volumes from routine pretreatment CT simulation scans.
(HealthDay News) — Less than 30% of women with estrogen receptor (ER)-positive early-stage breast cancer (ESBC) treated with lumpectomy remain adherent to endocrine therapy (ET) at 5 years, according ...
In this study, researchers aimed to assess the long-term relationship between adjuvant endocrine therapy adherence and hypertension, dyslipidemia, and diabetes, while also evaluating breast cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results